MAP2K1 and viral infectious disease: Previous studies have investigated the impacts of the MEK chemical inhibitors PD98059 and U0126 on JCPyV infection and found that upon inhibition of MEK, viral infectivity was significantly reduced, suggesting a pivotal role for MEK1/2 induction of ERK1/2 activity in facilitating viral infection [23,24,25].